Glucose Monitoring at the Thenar: Evaluation of Upper Dermal Blood Glucose Kinetics During Rapid Systemic Blood Glucose Changes

Abstract

Objective: We compared blood glucose measurements at the thenar with those at the fingertip during glucose increase and decrease that was rapid enough to induce glucose differences between the forearm and the fingertip. Methods: A rapid glucose increase was induced by oral glucose; subsequently, a rapid glucose decrease was induced by intravenous insulin in 16 insulin-treated patients with diabetes. Capillary samples were taken in parallel from the thenar and fingertip. Different glucose monitors (FreeStyle™, OneTouch®Ultra, Soft-Sense™) were used. Additional samples were taken from the forearm (n = 10 patients) in order to demonstrate that the blood glucose change achieved was rapid enough to principally induce glucose differences at alternative sites. Results: Neither blood glucose at baseline (135 ± 34 vs. 136 ± 41 mg/dl, p = 0.86) nor glucose amplitude during increase (190 ± 35 vs. 188 ± 41 mg/dl, p = 0.65) or decrease (255 ± 32 vs. 257 ± 45 mg/dl, p = 0.83) differed significantly between the fingertip and the thenar. Intra-individual average thenar-fingertip glucose difference was - 2 ± 12 (p = 1.00) and + 5 ± 9 mg/dl (p = 0.11). In the subgroup, intra-individual average forearm-finger difference was - 50 ± 19 (p < 0.01) and + 45 ± 11 mg/dl (p < 0.01) during glucose-increase and decrease, respectively. There were no obvious device-specific differences. Conclusions: Blood glucose measurements at the thenar are a safe alternative to measurements at the fingertip at steady state as well as during blood glucose change that is sufficiently rapid to induce clinically relevant differences between forearm and fingertip.

Key words

Alternative-Site Blood-Glucose Testing - Self-Monitoring of Blood Glucose - Fingertip - Dermal Blood Flow - Hypoglycaemia

References

• 1 Peled N, Wong D, Gwalani S L. Comparison of glucose levels in capillary blood samples obtained from a variety of body sites.  Diabetes Technology & Therapeutics. 2002;  4 35-44
• 2 Cunningham D D, Henning T P, Shain E B, Young D F, Elstrom T A, Taylor E J, Schroder S M, Gatcomb P M, Tamborlane W V. Vacuum-assisted lancing of the forearm: An effective and less painful approach to blood glucose monitoring.  Diabetes Technology & Therapeutics. 2000;  2 541-548
• 3 Feldman B, McGarraugh G, Heller A, Bohannon N, Skyler J, DeLeeuw E, Clarke D. FreeStyle™: A small sample electrochemical glucose sensor for home blood glucose testing.  Diabetes Technology & Therapeutics. 2000;  2 221-229
• 4 Fineberg S E, Bergenstal R M, Bernstein R M, Laffel L M, Schwartz S L. Use of an automated device for alternative site blood glucose monitoring.  Diabetes Care. 2001;  24 1217-1220
• 5 Suzuki Y. Painless blood sampling for self blood glucose measurement.  Lancet. 1992;  339 816-817
• 6 Berlin I, Bisserbe J C, Eiber R, Balssa N, Sachon F, Bosquet F, Grimaldi A. Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults.  Diabetes Care. 1997;  20 176-178
• 7 McGarraugh G. Response to Jungheim and Koschinsky: Glucose monitoring at the arm.  Diabetes Care. 2001;  24 1304-1306
• 8 Jungheim K, Koschinsky T. Risky delay of hypoglycemia detection by glucose monitoring at the arm.  Diabetes Care. 2001;  24 1303-1304
• 9 Jungheim K, Koschinsky T. Response Pfützner & Forst.  Diabetes Care. 2002;  25 639-640
• 10 Jungheim K, Koschinsky T. Glucose monitoring at the arm: Risky delays of hypoglycemia and hyperglycemia detection.  Diabetes Care. 2002;  25 956-960
• 11 Ellison J, Stegmann J, Ervin K, Horwitz D. Arm and thigh capillary blood glucose as alternatives to fingertip sampling in the management of diabetes (Abstract).  Diabetes. 2001;  50 (Suppl. 2) A111
• 12 McGarraugh G, Price D, Schwartz S, Weinstein R. Physiological influences on off-finger glucose testing.  Diabetes Technology & Therapeutics. 2001;  3 367-376
• 13 Fagrell B. Microcirculation of the skin. In: Mortillardo NA (ed) The physiology and pharmacology of the microcirculation. Orlando; Academic Press, 1. ed. 1984: 133-180
• 14 Rendell M, Bergman T, O’Donnel G, Drobny E, Borgos J, Bonner R F. Microvascular blood flow, volume and velocity measured by laser doppler techniques in IDDM.  Diabetes. 1989;  38 819-824
• 15 Stansberry K B, Peppard H R, Babyak L M, Popp G, McNitt P, Vinik A I. Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes.  Diabetes Care. 1999;  22 1549-1554
• 16 Pfützner A, Forst T. Response to Jungheim & Koschinsky.  Diabetes Care. 2002;  25 638-639
• 17 Fruhstorfer H, Mueller T, Scheer E. Capillary blood sampling: How much pain is necessary? Part 2: Relation between penetration depth and puncture pain.  Practical Diabetes International. 1995;  12 184-185
• 18 Bannister L H. Integumental system: skin and breasts. In Gray’s anatomy. The anatomical basis of medicine and surgery. Williams PL (ed) London; Churchill Livingstone, 38. ed. 1995: 375-424
• 19 Koschinsky T, Dannehl K, Gries F A. New approach to technical and clinical evaluation of devices for self-monitoring of blood glucose.  Diabetes Care. 1988;  11 619-629